NEW YORK (AP) _ Tonix Pharmaceuticals Holding Corp. (TNXP) on Monday reported a loss of $7.5 million in its fourth quarter.
On a per-share basis, the New York-based company said it had a loss of $2.08. Losses, adjusted for non-recurring costs, were $1.77 per share.
For the year, the company reported that its loss widened to $38.8 million, or $15.41 per share.
The company's shares closed at $4.79. A year ago, they were trading at $27.20.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TNXP at https://www.zacks.com/ap/TNXP
Keywords: Tonix Pharmaceuticals, Earnings Report
Your email address will not be published. Required fields are marked *
JB Hunt tops 1Q profit forecasts
Williams Partners Agrees to Sell Its Interests in the Geismar Olefins Facility to NOVA Chemicals for $2.1 Billion; Announces Long-Term Feedstock Supply and Transportation Agreements with NOVA Chemicals